Hyo Jeong Hong Selected Research

Hyo Jeong Hong Research Topics

Disease

18	Neoplasms (Cancer) 10/2019 - 03/2006
8	Cholangiocarcinoma 10/2019 - 12/2009
4	Infections 07/2021 - 02/2008
4	Carcinoma (Carcinomatosis) 10/2011 - 03/2006
2	Neoplasm Metastasis (Metastasis) 05/2011 - 04/2011
1	Fibrosis (Cirrhosis) 01/2021
1	Cardiotoxicity 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Cholera 11/2020
1	COVID-19 07/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015
1	Colonic Neoplasms (Colon Cancer) 03/2015
1	Breast Neoplasms (Breast Cancer) 06/2014
1	Stomach Neoplasms (Stomach Cancer) 11/2013
1	Myocardial Infarction 05/2011
1	Ischemia 05/2011
1	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2011
1	Carcinoid Tumor (Carcinoid) 02/2009
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2009
1	Wounds and Injuries (Trauma) 03/2006
1	Adenocarcinoma 03/2006
1	Vascular Remodeling 02/2005

Drug/Important Bio-Agent (IBA)

13	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2021 - 02/2009
6	Proteins (Proteins, Gene)FDA Link 07/2020 - 03/2006
4	Monoclonal AntibodiesIBA 07/2021 - 02/2009
4	AntibodiesIBA 07/2020 - 02/2008
3	Therapeutic UsesIBA 01/2017 - 03/2006
3	Glycoproteins (Glycoprotein)IBA 03/2015 - 03/2006
2	Trastuzumab (Herceptin)FDA Link 01/2018 - 11/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 11/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 03/2012
2	AntigensIBA 06/2014 - 07/2010
2	tumor-associated antigen 72IBA 12/2007 - 03/2006
1	Neutralizing AntibodiesIBA 07/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	LipopolysaccharidesIBA 11/2020
1	Lipid AIBA 11/2020
1	O Antigens (O Antigen)IBA 11/2020
1	Polysaccharides (Glycans)IBA 11/2020
1	SARS-CoV-2 spike proteinIBA 07/2020
1	EpitopesIBA 07/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 10/2019
1	Chelating AgentsIBA 10/2019
1	AcidsIBA 10/2019
1	sodium-bile acid cotransporterIBA 08/2018
1	Cetuximab (Erbitux)FDA Link 01/2018
1	Cell Adhesion MoleculesIBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	EndostatinsIBA 03/2015
1	Angiogenesis InhibitorsIBA 03/2015
1	RNA (Ribonucleic Acid)IBA 06/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2013
1	Epidermal Growth Factor (EGF)IBA 11/2013
1	Bevacizumab (Avastin)FDA Link 11/2013
1	afliberceptIBA 11/2013
1	Vascular Endothelial Growth Factor BIBA 11/2013
1	Immunoglobulin G (IgG)IBA 04/2012
1	ErbB Receptors (EGF Receptor)IBA 03/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2011
1	Small Interfering RNA (siRNA)IBA 07/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2008
1	B72.3 antibodyIBA 12/2007
1	Thrombopoietin (c-mpl Ligand)IBA 04/2006
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2006
1	Cartilage Oligomeric Matrix ProteinIBA 03/2006
1	TIE-2 Receptor (Receptor, TIE 2)IBA 02/2005
1	Angiopoietin-2IBA 02/2005

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 10/2019 - 04/2006
6	Therapeutics 01/2021 - 03/2006
3	Radiotherapy 10/2019 - 04/2012
1	Radioimmunotherapy 10/2019
1	Precision Medicine 10/2019